I found this kind of interesting, I just wonder if we will still be kept in the dark on "results".
◾Organize the abstract according to four sections, identified by the following headers: Background, Methods, Results, and Conclusions. (Note: Trials in Progress abstract submissions should only include Background and Methods sections. Any preliminary data including toxicity, response rate, pharmacokinetic, or correlative analysis should not be included in the abstract.)
As a general rule, ASCO discourages submission of abstracts that report interim data from studies that are continuing to accrue patients (examples include phase I studies where recommended phase II dose is not yet determined, or phase II studies that are not fully enrolled). Acceptance of such abstracts will be considered on a case-by-case basis.
An abstract is just that,an abstract.The verbal contractions in the abstract, are standard procedure in any science society to limit publication space and costs in the published Proceedings which are handed without cost , to those who REGISTER and attend ...The actual ORAL presentation at ASCO can be expanded to include rates of efficacy,side effects etc etc,provided the presenter remains within his allocated TIME LIMITS.Hundreds of papers are read at these meetings.But only the abbreviated abstracts are published in print.